A new, powerful Citizen Portal experience is ready. Switch now

Georgia House creates study committee to probe pharmacy benefit managers

March 09, 2026 | 2026 Legislature Georgia, Georgia


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Georgia House creates study committee to probe pharmacy benefit managers
The Georgia House on March 9 adopted House Resolution 948, establishing a study committee to examine pharmacy benefit managers and consumer access to prescription medications.

Representative Ron Stevens, who presented the committee substitute on the House floor, said the panel will “reverse engineer” how employers and self-insured plans are billed and examine mail-order and 340B pharmacy arrangements. “We’re gonna see if we can find out exactly what employers are being billed versus what they’re paying on these self insurance plans,” Stevens said, and described the inquiry as aimed at understanding how PBMs’ commercial arrangements affect plan costs.

The study committee was created by a committee substitute that the House adopted without objection. On the subsequent passage vote, the clerk recorded 157 yeas and 0 nays; the resolution therefore carried the requisite constitutional majority.

Why it matters: PBMs administer prescription benefits for many employers and insurers; supporters of the study argued the committee could identify gaps between prices charged and amounts passed to plans, potential effects of mandatory mail-order rules, and whether current practices affect cost and access for patients.

What the resolution does and next steps: HR 948 directs the House to form a study committee that will hold hearings and request information from stakeholders and state agencies; no statutory changes were adopted on the floor. The resolution’s sponsor said the committee will probe PBM practices, profit flows, and whether market structures affect consumers’ access to medications. The House did not set a final reporting date on the floor during the session’s adoption.

The clerk read the resolution’s caption and committee referral before the presentation and vote; the committee substitute was agreed to on the floor and then approved by recorded vote. The study committee’s meetings, witnesses and any staff work will be public records once scheduled by the committee.

View the Full Meeting & All Its Details

This article offers just a summary. Unlock complete video, transcripts, and insights as a Founder Member.

Watch full, unedited meeting videos
Search every word spoken in unlimited transcripts
AI summaries & real-time alerts (all government levels)
Permanent access to expanding government content
Access Full Meeting

30-day money-back guarantee